# TERBUTALINE SULFATE
> **ANDA200122** · Abbreviated New Drug Application (Generic) · Sponsor: AREVA PHARMS · Approved 2013-11-08
## Drug
- **FDA Application Number:** ANDA200122
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TERBUTALINE SULFATE
- **Generic name:** Terbutaline Sulfate
- **Active ingredients:** TERBUTALINE SULFATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** AREVA PHARMS
- **First approval:** 2013-11-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200122)
---
*MORVS · CC0 1.0*